Innovata of the UK has sold off its gene expression technology UCOE
to Celliance Corp, a wholly owned subsidiary of Serologicals, for
an undisclosed fee.
Chromos Molecular Systems won another customer for its cell line
engineering technology yesterday, when world number one drugmaker
Pfizer took out a license for its ACE system, reports Phil
Taylor.
Cambridge Antibody Technology of the UK has signed up for a
non-exclusive licence to a technology, developed by Canada's
Chromos Molecular Systems, for the commercial manufacture of
biologics.